Adipose-derived stem cells for wound healing applications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21200308.
- Also identified by DOI 10.1097/SAP.0b013e3181e6d06c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nonhealing wounds remain a significant challenge for plastic surgeons. More than 600,000 people suffer from venous ulcers and 1.5 to 3 million people are being treated for pressure sores every year in the United States. The use of tissue engineering techniques such as stem-cell therapy and gene therapy to improve wound healing is a promising strategy. Adipose tissue represents a source of cells that may be able to enhance wound healing. Adipose-derived stem cells (ASCs) are adult stem cells that are easily harvested and of great interest for plastic surgeons. Specifically, ASCs secrete angiogenic growth factors that can induce tissue regeneration. This review describes innovative research strategies using ASCs therapies for treatment of chronic, nonhealing wounds.
Medical subject headings
- Adipose Tissue
- Stem Cell Transplantation
- Stem Cells
- Wound Healing
- Wounds and Injuries